soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore
DeviceTEST Lens
NCT Number: NCT05344560
This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treament, 2-sequence, 3-period crossover study to evalulate overall vision and comfort..
Looking for future studies?
Notify Me18 year–39 year
All sexes
Interventional
Not applicable
Dr. James Weber & Associates, PA - City Square Blvd, Jacksonville, Florida, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Potential subjects must satisfy of all the following criteria to be enrolled in the study.
Exclusion criteria
Potential subjects who meet any of the following criteria will be excluded from participating in the study:
TEST Lens
CONTROL Lens
Time frame: 1-Week Follow-up
Subjective comfort was assessed using Contact Lens User Experience (CLUE) questionnaire. CLUE is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (Comfort, Vision, Handling, and Packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution where scores range from 0 to 120 with a population average score of 60 (SD 20). Higher CLUE scores indicate a more favorable/positive response. The average CLUE comfort score was report for each lens type.
Johnson & Johnson Vision Care, Inc.
Industry
Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light Produced on Commercial Manufacturing Lines
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07174596
Visual Acuity
Roswell, Georgia, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT06864858
Visual Acuity
Maitland, Florida, United States
View Trial DetailsNCT07443215
Visual Acuity
Jacksonville, Florida, United States
View Trial Details